Nucleoside reverse transcriptase inhibitors (RTIs) were the first class of drugs approved for the treatment of AIDS. The human body breaks down this type of drug into compounds that stop HIV from infecting uninfected cells, however RTIs exhibit no effect on preinfected cells.